111
Participants
Start Date
December 8, 2010
Primary Completion Date
October 1, 2015
Study Completion Date
December 13, 2016
AMG 337
AMG 337 is a small molecule inhibitor of c-Met which is a receptor tyrosine kinase expressed on the surface of epithelial cells.
Research Site, Atlanta
Research Site, Nashville
Research Site, Columbus
Research Site, Detroit
Research Site, Chicago
Research Site, Houston
Research Site, Los Angeles
Research Site, Boston
Lead Sponsor
Amgen
INDUSTRY